IL6 and chronic obstructive pulmonary disease: IL-6 (Figure 5B) and IL-17 (Figure 5C) levels were significantly elevated in the CS group compared with the control and downregulated in AK-7 group in a dose-dependent manner compared with the CS-induced COPD group.